Health Science Technology Training
for Software and Data Professionals
*Applications open until May 17*
| |
Applications are now open for the second cohort of our national upskilling program! This training program addresses the shortage of multidisciplinary tech professionals in the health science industry by integrating traditional software skills with industry-specific knowledge. It also connects participants with potential employers and provides exposure to new and innovative practices to prepare them for a role in the health science industry.
| |
|
The program runs from June 3 to September 6, 2024 (14 weeks):
Part I – Core Training Course (Weeks 1 & 2)
Dates: June 3 - 14, 2024
Time: 9 am – 1 pm daily
Format: Virtual
Part II – Job Placement Support (Weeks 3 to 14)
Format: Hybrid format
During this time, program participants will have access to a range of benefits, including:
- One-on-one career development mentorship
- Resume and interview preparation
- Networking events
- Workshops for job placement support
| |
Enrolment space is limited and eligible candidates will be selected on a rolling basis. | | |
|
How to make your Biotech Data AI ready
Live Workshop / May 9 / 12–2:30 pm EDT
| |
The workshop, hosted by Scispot in partnership with OBIO®, is designed specifically for biotech companies aiming to become
AI-ready. The workshop is an opportunity to engage with leading experts who will guide you through the creation of a robust data infrastructure, crucial for establishing a competitive edge and fully leverage AI technologies in your operations.
| |
CHEO and PolyUnity bring 3D printing solutions
to Ontario healthcare | |
|
Leveraging a successful evaluation between OBIO’s Early Adopter Health Network (EAHN™), PolyUnity, and CHEO in 2022-23, we are excited to share that CHEO has selected PolyUnity to bring 3D printing solutions to Ontario healthcare. The partnership builds on the positive outcomes of the evaluation on how a digital inventory and 3D printing solutions could help solve supply chain issues, reduce costs, and create operational efficiencies.
The evaluation resulted in more than 200 new innovations, 1,281 products delivered, and 460 pieces of equipment repaired and returned to service, leading to a successful adoption of the solution.
| |
16Bit receives FDA De Novo marketing authorization for Rho™ | |
|
16 Bit Inc., a software medical device company, recently announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rho™, an AI-enabled software device aimed at improving a known care gap in osteoporosis screening. Rho received Breakthrough Device designation by the FDA in March 2021, signifying the first FDA-authorized radiology software for opportunistic evaluation of low bone mineral density (BMD).
| |
16Bit is an alumnus of our BDSP™ and H2BB™ programs, presented at the OBIO® Investment Summit, and is a part of our Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence technology adoption stream. | |
Hyivy Health featured in the Globe and Mail | |
Read this story published in the Globe and Mail on the femtech companies and the important work they are doing to tackle gender health gaps and shift the focus on women’s health. We are elated to see Rachel Bartholomew, Founder and CEO, Hyivy Health and other amazing women founders recognized for the tremendous impact they are making in women’s health in this article.
| Hyivy Health is an alumnus of our BDSP™, CAAP®, EAHN™ and WiHI programs, and presented at the OBIO® Investment Summit. | |
Morphocell Technologies announces completion of US$40 Million Series A financing | |
|
Morphocell Technologies Inc., a Montreal-based biotechnology company in the cell therapy space, recently announced the closure of a US$40 million Series A funding round. The funding is set to fuel the company’s groundbreaking journey towards a first-in-human clinical trial of the first cell therapy issued from its tissue engineering platform, aimed at transforming liver disease treatment globally.
| Morphocell Technologies is an alumnus of our CAAP® program and presented at the OBIO® Investment Summit. | |
CEOs of HDAX Therapeutics and Noa Therapeutics selected among the 2024 Termeer Fellows | |
|
The Termeer Fellowship Program recently announced the class of 2024 Termeer Fellows – a group of fifteen visionary leaders who are passionate about transforming patient care through innovations. The fellows will receive leadership programming, mentorship, and access to a network of industry leaders.
| |
|
Congratulations to the selected leaders! Shout-out to Nabanita Nawar, CEO and Co-founder, HDAX Therapeutics and Carla Spina, CEO and Co-founder, Noa Therapeutics!
HDAX Therapeutics and Noa Therapeutics are OBIO® members and alumni of our BDSP™ and WiHI programs.
| |
Rocket Doctor selected for the inaugural cohort of the Google for Startups Accelerator | |
|
Rocket Doctor, a technology-driven digital health platform and marketplace that empowers healthcare providers to break down the barriers that prevent patients from accessing care, has been selected for the inaugural cohort of the Google for Startups Accelerator: AI First North America. The program will provide 10 weeks of hands-on mentorship and technical project support to start-ups using AI in their core service or product. Selected start-ups will collaborate with a cohort of top peer founders and engage with leaders across Google.
| Rocket Doctor is an alumnus of our BDSP™ and CAAP® programs, presented at the OBIO® Investment Summit, and is a beneficiary of our Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence. | |
Industry News, Events & Funding Opportunities | | |
April - November 2024 events | | |
|
For members selling medical sharps
Today I Webinar
| Join the webinar to get updates on the new regulatory landscape in New Brunswick and Quebec, impacting brand owners selling medical sharps. | |
|
Discount for the MedTech Conference
Sign up before April 19
| |
Lock in the lowest rate for the MedTech Conference! The MTC Flex Pass opportunity is open from March 19 – April 19. Contact
Lily Doerfler for questions.
| |
|
Applications open for NERVE Program
Deadline: April 21
| The NERVE program offers $100,000 in non-dilutive funding, 12 months of training opportunities, 1:1 mentorship and commercialization support to Canadian-based entrepreneurs building a neurotechnology or brain-health related company. | |
|
Pre-Tournament Golf & Networking
April 23 I Toronto
| Join LSO’s Pre-Golf Classic networking event at The Sand Trap Golf Simulator & Lounge. There will be food and drinks for all attendees, opportunities to network, and prizes to win. | |
|
Regulatory & Quality Medtech Conference
April 23-24 I Ottawa
| Canada’s Regulatory & Quality Medtech Conference 2024 presented by Medtech Canada is the go-to regulatory & quality conference for the medical technology industry. | |
|
CITM Innovation Challenges
Deadline: April 28
| Applications are open for the CITM Innovation Challenges! Are you an innovative startup or SME with a solution for a new era of smart, connected transportation? | |
|
Tackle cybersecurity challenges unique to the life sciences & digital health
First webinar on April 29
| Take part in programs on cyber technology adoption and best practices for the life sciences and digital health sector, brought to you by Rogers Cybersecure Catalyst and Canadian Cyber Threat Exchange (CCTX). | |
|
Internship Opportunity
Deadline: April 30
| Are you scouting for talent in biotechnology research and development? Consider taking on a student from the University of Toronto HMB491 -Projects in Biotechnology industry course. For more info, write to Naomi Levy-Strumpf. | |
|
Life Sciences
Investor Day
May 8 I Toronto
| Join the event to hear presentations from some of the most innovative public and private life sciences companies from across Canada. Detailed agenda and list of companies will be announced soon. | |
|
Growing & building an early-stage AI venture in life sciences
May 14 I Toronto
| The event will bring together industry leaders, founders, investors, and academics in the AI field in life sciences to discuss the latest insights and strategies for early-stage AI ventures in life sciences. | |
|
LSO Awards Presentation
May 15 I Toronto
| The LSO Awards are an important part of the organization’s goal to advocate for Ontario’s life sciences sector, by celebrating the individuals and companies behind its success. | |
|
Obtain funds for R&D with SyngeriQc
Deadline: May 15
| SynergiQc facilitates biopharma innovation by consolidating public-private partnerships between university researchers and Quebec companies, to generate economic benefits for Quebec. | |
|
CQDM is looking for
world-class research to develop novel and efficient approaches for obesity and metabolic disorders therapeutics to present to domain experts from leading
global pharmaceutical organizations on CQDM Connect-Pharma: Pitch Day.
| |
|
Cyber Sec and Infosecurity Europe
May 27 - June 6
| The mission to Cybersecurity and Infosecurity Europe 2024 represents a unique opportunity for innovative Ontario ICT companies to get introduced to potential clients, partners from UK, Belgium, and across Europe. | |
|
UTEST Applications
Deadline: May 30
| |
The UTEST Program is announcing its annual call for research-based UofT and affiliated research hospital companies. UTEST can provide start-up companies with investment/funding opportunities, intense entrepreneurial education corporate and intellectual property legal support,
and more.
| |
|
Funds for drug discovery research
Deadline: May 30
| CQDM's program, Quantum Leap, helps Canadian SMEs and universities carry out innovative translational research projects in biopharmaceuticals. The selected projects aim to develop cutting-edge technologies with a significant potential impact on the R&D activities of CQDM's pharmaceutical members. | |
|
Applications open for CanExport SMEs funding program
Deadline: May 31
| This program provides up to $50,000 (matching your contribution) to small and medium-sized enterprises (SMEs) registered in Canada for international business development activities. Applications are processed on a first-come, first-served basis. | |
|
The Age of AI
Deadline: June 18
| At this event, industry leaders from Roche, Takeda, AstraZeneca, Klick Health, EY, PAAB, DLA Piper, and many more will share how AI is creating exponential business and brand value. Know how to enhance the value you provide to healthcare professionals and patients with AI. | |
|
BioCreate cohorts
4 & 5 are open!
Deadline: June 23
| The BioCreate program is now open to SMEs in southern Ontario looking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture, and cleantech sectors at a Technology Readiness Level (TRL) of 4+. | |
|
LSO Golf Classic
August 14 I Brampton
| This event provides an important and engaging environment for the life sciences community and supports crucial programs, including LSO's policy and advocacy work, and mentorship programs. | |
|
ON Trade Mission to
BIO-Europe
Nov – 4-6 I Stockholm
| |
Delivered in collaboration with the Trade Commissioner Service and BIOTECanada, the mission program will include registration for
BIO-Europe, networking and more. For more info, contact Patrick Barry.
| |
Science Horizons Youth Internship | |
The program helps
bio-economy, healthcare, and environmental employers hire the talent they need and helps graduates gain skills to secure full-time employment. For further info, please contact
Jennifer Ash.
| |
Calling companies to collaborate with Mayo Clinic | |
Medical Alley is working with the Mayo Clinic to source company partnerships in two areas: surgical innovations and artificial intelligence.
Contact Frank Jaskulke for more info.
| |
EY Entrepreneurial Winning WomenTM North America | |
The program annually identifies a select group of high-potential founders who have built profitable companies and provides them with connections and vast resources needed to think bigger and sustainably scale their companies to
full potential.
| |
Opportunity to engage Schulich students | Students from the Schulich School of Business Master of Health Industry Administration, supervised by faculty with real world experience, are available to help you, analyze your business and its competitive environment. For more info, please contact Dr. Minerva Cernea. | |
The Career Starter Program facilitates the transition of barriered youth into the labour market. It bridges the gap between talent and industry, introduces participants to bio-economy as a viable career path, and enables employers to strengthen their workforce. | |
Regional Development Program | The program supports eligible SMEs investing in new equipment and training to expand operations in these regions, and also provides support to municipalities and economic development organizations investing in economic development projects. | | | | |
